-
The Intricate Web of MicroRNAs in Modulating EGFR-TKI Resistance in Non-Small Cell Lung Cancer: A Comprehensive Review
11 Nov 2025 07:13 GMT
… osimertinib resistance in lung cancer by inhibiting the CD44 … sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways … non-small cell lung cancer. Transl Lung Cancer Res. 2022;11 … microRNA-21 inhibitor and doxorubicin. Colloids Surf B …
-
<![CDATA[Efforts to Leverage NaPi2b Are Renewed With Novel ADC in Ovarian Cancer]]>
13 Nov 2025 20:23 GMT
… nonsquamous non–small cell lung cancers (NSCLC), underscoring its … 1 months with pegylated liposomal doxorubicin (n = 48; HR … the data from the lung cancer cohort, [which will … compared with pegylated liposomal doxorubicin in patients with platinum- …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer.
Current treatment modalities for lung cancer include … CPT-NPs inhibited lung tumor growth by … doxorubicin to promote necroptosis for mitigating lung cancer cells …
-
Breakthrough Nanobody Tech Hits Lung Cancer Cells Like a Drone Strike
19 Aug 2025 19:12 GMT
… precisely identify and attack lung cancer cells—sparing surrounding … in high abundance on lung cancer cells.
The A5 … containing the anticancer drug doxorubicin (DOX).
This design … of lung cancer adenocarcinoma cells.
Pink visual of lung cancer adenocarcinoma …
-
Precision Nanobody Therapy Breaks New Ground in Targeting Lung Cancer Tumors
15 Aug 2025 20:19 GMT
… precision in attacking lung cancer cells. This novel … threefold increase in doxorubicin uptake within lung cancer cells. This … , non-small cell lung cancer
Tags: breakthrough cancer … effectsnon-small cell lung cancer innovationsprecision medicine in …
-
Amentoflavone Impedes NF-κB Activation and Mediates Apoptosis Induction in Lung Cancer Cells: An in vitro and in silico exploration
01 Jul 2025 12:03 GMT
… clinical management of lung cancer by investigating various … to therapeutic interventions in lung cancer.20,21 Consequently, … (b) amentoflavone, (c) doxorubicin, (d) JSH-23, and … treatment of cancers, including lung cancer. Currently, available therapeutic …
-
StockWatch: Recursion Slides on Data Update as New CEO Named
09 Nov 2025 21:15 GMT
… )
Pancreatic cancer
Non-small cell lung cancer (NSCLC)
Breast cancer (hormone receptor … , plus paclitaxel or pegylated liposomal doxorubicin (PLD).
Full data from ELUCIDATE …
-
Theranostic Role of Advanced Nanotechnological Tools in Early Brain Metastases in Lung Cancer: An Updated Review
05 Jun 2025 21:28 GMT
… cells from the initial lung tumor, their migration into … Brain Metastasis in Lung Cancer. Primary lung cancer cells move from … In contrast to original lung tumors, which might manifest … formulations is liposome-encapsulated doxorubicin (Doxil), which is …
-
In vivo Targeted Delivery of Extracellular Vesicle‒Gold Nanorod Hybrids to Metastatic Melanoma Lung Tumors
30 May 2025 18:07 GMT
… of metastatic melanoma lung tumors in vivo with … al. Targeted delivery of doxorubicin by nano-loaded mesenchymal … study protocol among advanced lung cancer patients. Front Public Health … accumulation in small metastatic lung tumors. J Nanobiotechnology. 2020 …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… ) and non-small cell lung cancer (NSCLC). In patients with … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … nonsquamous non-small cell lung cancer (NSCLC), with no … and paclitaxel followed by doxorubicin or epirubicin and cyclophosphamide) …
About
© 1995-2025